HealthLynked Corp. is a growth stage company incorporated in the state of Nevada on August 6, 2014. We currently operate in two distinct divisions: Health Services and Digital Healthcare. Our Health Services division is comprised of the operations of (i) Naples Women’s Center (“NWC”), a multi-specialty medical group including OB/GYN (both Obstetrics and Gynecology), and General Practice, and (ii) Naples Center for Functional Medicine (“NCFM”), a Functional Medical Practice acquired in April 2019 that is engaged in improving the health of its patients through individualized and integrative health care. Our Digital Healthcare division develops and plans to operate an online personal medical information and record archive system, the “HealthLynked Network,” which will enable patients and doctors to keep track of medical information via the Internet in a cloud-based system.
Company profile
Ticker
HLYK
Exchange
Website
CEO
Michael T. Dent
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Naples Women’s Center, LLC • HLYK Florida, LLC • ACO Health Partners LLC • Bridging the Gap Physical Therapy LLC • MEDOFFICEDIRECT L.L.C. • Naples Advanced Women’s Care, LLC • Aesthetic Enhancements Unlimited, LLC ...
HLYK stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
14 Mar 24
8-K
Departure of Directors or Certain Officers
11 Jan 24
8-K
Other Events
27 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
8-K
Other Events
21 Mar 23
8-K
HealthLynked Announces Appointment of Paul J. Hobaica, MD to its Board of Directors
15 Mar 23
8-K
HealthLynked Announces Sale of ACO Health Partners
23 Jan 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 51.33 k | 51.33 k | 51.33 k | 51.33 k | 51.33 k | 51.33 k |
Cash burn (monthly) | 289.21 k | 8.90 k | 394.95 k | 625.11 k | 416.44 k | 296.08 k |
Cash used (since last report) | 1.73 mm | 53.21 k | 2.36 mm | 3.74 mm | 2.49 mm | 1.77 mm |
Cash remaining | -1.68 mm | -1.88 k | -2.31 mm | -3.68 mm | -2.44 mm | -1.72 mm |
Runway (months of cash) | -5.8 | -0.2 | -5.8 | -5.9 | -5.9 | -5.8 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Sep 23 | Paul Hobaica | Common Stock | Grant | Acquire A | No | No | 0 | 408,163 | 0.00 | 569,107 |
27 Sep 23 | Robert P Gasparini | Common Stock | Grant | Acquire A | No | No | 0 | 408,163 | 0.00 | 2,880,191 |
27 Sep 23 | Daniel L. Hall | Common Stock | Grant | Acquire A | No | No | 0 | 408,163 | 0.00 | 1,181,697 |
27 Sep 23 | Heather Monahan | Common Stock | Grant | Acquire A | No | No | 0 | 408,163 | 0.00 | 1,181,697 |